PainChek Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

PainChek şirketinin toplam hissedar öz sermayesi A$1.3M ve toplam borcu A$0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla A$4.2M ve A$2.9M dir.

Anahtar bilgiler

Borç/özkaynak oranı

AU$0

Borç

Faiz karşılama oranı	n/a
Nakit	AU$3.56m
Eşitlik	AU$1.29m
Toplam yükümlülükler	AU$2.89m
Toplam varlıklar	AU$4.18m

Son finansal sağlık güncellemeleri

Recent updates

We're Keeping An Eye On PainChek's (ASX:PCK) Cash Burn Rate

Jul 04

Is PainChek (ASX:PCK) In A Good Position To Invest In Growth?

Feb 08

Will PainChek (ASX:PCK) Spend Its Cash Wisely?

Jul 05

Companies Like PainChek (ASX:PCK) Can Afford To Invest In Growth

Jan 26

We're Interested To See How PainChek (ASX:PCK) Uses Its Cash Hoard To Grow

Sep 07

When Can We Expect A Profit From PainChek Limited (ASX:PCK)?

May 07

PainChek (ASX:PCK) Is In A Strong Position To Grow Its Business

Mar 01

Market Sentiment Around Loss-Making PainChek Limited (ASX:PCK)

Nov 20

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: PCK 'nin kısa vadeli varlıkları ( A$4.2M ) kısa vadeli yükümlülüklerini ( A$2.9M ) aşıyor.

Uzun Vadeli Yükümlülükler: PCK un uzun vadeli yükümlülüğü bulunmamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: PCK borçsuzdur.

Borcun Azaltılması: PCK son 5 yıldır borcu bulunmamaktadır.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: PCK şirketinin mevcut serbest nakit akışına göre bir yıldan az nakit akışı süresi bulunmaktadır.

Tahmini Nakit Akışı: PCK un, serbest nakit akışı her yıl % 18.5 oranında tarihi oranda azalmaya devam ederse bir yıldan az nakit akışı süresi vardır

PainChek Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

We're Keeping An Eye On PainChek's (ASX:PCK) Cash Burn Rate

Is PainChek (ASX:PCK) In A Good Position To Invest In Growth?

Will PainChek (ASX:PCK) Spend Its Cash Wisely?

Companies Like PainChek (ASX:PCK) Can Afford To Invest In Growth

We're Interested To See How PainChek (ASX:PCK) Uses Its Cash Hoard To Grow

PainChek (ASX:PCK) Is In A Strong Position To Grow Its Business

Recent updates

PainChek Limited to Report Q4, 2024 Results on Oct 30, 2024

PainChek Limited, Annual General Meeting, Nov 28, 2024

Full year 2024 earnings released: AU$0.006 loss per share (vs AU$0.006 loss in FY 2023)

PainChek Limited has filed a Follow-on Equity Offering in the amount of AUD 2.5 million.

PainChek Limited Announces Change of Company Secretary

PainChek Limited has completed a Follow-on Equity Offering in the amount of AUD 3.55 million.

Full year 2023 earnings released: AU$0.006 loss per share (vs AU$0.005 loss in FY 2022)

New minor risk - Shareholder dilution

Full year 2023 earnings released: AU$0.006 loss per share (vs AU$0.005 loss in FY 2022)

PainChek Limited, Annual General Meeting, Nov 22, 2023

New minor risk - Financial data availability

New minor risk - Share price stability

We're Keeping An Eye On PainChek's (ASX:PCK) Cash Burn Rate

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.002 loss in 1H 2022)

Is PainChek (ASX:PCK) In A Good Position To Invest In Growth?

PainChek Limited Announces Company Secretary Changes

No independent directors

PainChek Limited, Annual General Meeting, Nov 23, 2022

Forecast to breakeven in 2025

Painchek Limited to Receive Govt Funding for Children's Disability App

Will PainChek (ASX:PCK) Spend Its Cash Wisely?

Consensus forecasts updated

No independent directors

PainChek Ltd Appoints Cynthia Payne as Non-Executive Director, Effective 30 March 2022

Consensus forecasts updated

Forecast breakeven date pushed back to 2024

Companies Like PainChek (ASX:PCK) Can Afford To Invest In Growth

We're Interested To See How PainChek (ASX:PCK) Uses Its Cash Hoard To Grow

Full year 2021 earnings released: AU$0.005 loss per share (vs AU$0.013 loss in FY 2020)

PainChek Limited Infant Achieves International Regulatory Clearances

When Can We Expect A Profit From PainChek Limited (ASX:PCK)?

PainChek (ASX:PCK) Is In A Strong Position To Grow Its Business

PainChek Limited Announces Successful Completion of Infant Face-Only Clinical Study

Market Sentiment Around Loss-Making PainChek Limited (ASX:PCK)

Full year earnings released - AU$0.013 loss per share

PainChek Ltd. announced that it expects to receive AUD 10 million in funding

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin